B Group, Inc. has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $130 Billion distributed in 17 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Adma Biologics, Inc. with a value of $42.2B, Insmed Inc with a value of $15.6B, Zai Lab LTD with a value of $14B, Akero Therapeutics, Inc. with a value of $12.4B, and Cellectis S.A. with a value of $4.97B.

Examining the 13F form we can see an increase of $13.2B in the current position value, from $117B to 130B.

B Group, Inc. is based out at Dallas, TX

Below you can find more details about B Group, Inc. portfolio as well as his latest detailed transactions.

Portfolio value $130 Billion
Healthcare: $107 Billion

Stock Holdings Table Companies Only

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 17
  • Current Value $130 Billion
  • Prior Value $117 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 0 stocks
  • Additional Purchases 8 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 3 stocks
Track This Portfolio

Track B Group, Inc. Portfolio

Follow B Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of B Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on B Group, Inc. with notifications on news.